HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
- £6.78m
- £7.88m
REG - Hemogenyx Pharma Plc - Total Voting Rights
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 05/10/2023
AnnouncementREG - Hemogenyx Pharma Plc - Half-year Report
AnnouncementREG - Hemogenyx Pharma Plc - Strategic Investment from Prevail Partners, LLC
AnnouncementREG - Hemogenyx Pharma Plc - Clinical Hold Lift Plan is accepted by FDA
AnnouncementRCS - Hemogenyx Pharma Plc - CBR Patent Application Update
AnnouncementREG - Hemogenyx Pharma Plc - Full FDA Review for HEMO-CAR-T IND
AnnouncementREG - Hemogenyx Pharma Plc - Result of Annual General Meeting
AnnouncementREG - Hemogenyx Pharma Plc - Posting of Annual Report & Notice of AGM
AnnouncementREG - Hemogenyx Pharma Plc - Clinical Hold on IND for HEMO-CAR-T
AnnouncementREG - Hemogenyx Pharma Plc - Submission of IND for HEMO-CAR-T
AnnouncementREG - Hemogenyx Pharma Plc - Equity Incentive Pool Increase and Option Grant
AnnouncementREG - Hemogenyx Pharma Plc - Final Results for the Year Ended 31 December 2022
AnnouncementRCS - Hemogenyx Pharma Plc - HEMO-CAR-T Analytical Release Tests Completed
AnnouncementREG - Hemogenyx Pharma Plc - Total Voting Rights
AnnouncementREG - Hemogenyx Pharma Plc - Admission of Shares to Official List
AnnouncementREG - Hemogenyx Pharma Plc - Price Monitoring Extension
AnnouncementREG - Hemogenyx Pharma Plc - Second Price Monitoring Extn
Announcement